Long-Term Storage Stability of Corticotropin Investigated
|
By LabMedica International staff writers Posted on 20 Dec 2021 |

Image: The ARCHITECT i2000SR automated immunoassay instrument system (Photo courtesy of Abbott Laboratories)
Corticotropin (adrenocorticotropic hormone, ACTH) is a 39-residue polypeptide tropic hormone secreted by the anterior pituitary gland following hypothalamic corticotropin-releasing hormone release. Corticotropin is notorious for its instability.
Cortisol regulates ACTH release via a negative feedback loop. Measurements of plasma ACTH are crucial for differential diagnosis of endocrine disorders including Cushing’s syndrome and adrenal insufficiency but can be complicated by both preanalytical and analytical factors.
Clinical Biochemists at Amsterdam University (Amsterdam, The Netherlands) and their colleagues investigated the long-term storage stability of corticotropin in ethylenediaminetetraacetic acid containing plasma. Plasma specimens were obtained from 20 healthy American subjects that were either neat or spiked with ACTH (22–1,866 pg/ml). Plasma specimens were also obtained from Dutch patients visiting the Amsterdam University Medical Centers (UMC, Amsterdam, The Netherlands), between 2012 and 2013 for various indications.
Individual specimens were assayed on the day of processing (month 0) and five times (at 1, 3, 9, 12, and 18 months) following storage at both −20 °C and −70 °C in five replicates each. Specimens were thawed once on the laboratory countertop at room temperature, mixed by gentle inversion and centrifuged at 3,000×g for 5 minutes Afterwards they were kept at room temperature and quickly analyzed. ACTH results were generated on the ARCHITECT i2000SR automated immunoassay instrument system (Abbott Laboratories, Abbott Park, IL, USA). The team also used a chemiluminescence immunoassay (CLIA) that uses two monoclonal antibodies of which the Liaison capture antibody that is coated to magnetic particles and the detection antibody is linked to an isoluminol derivative (Diasorin, Salugia, Italy).
The team reported that storing human plasma specimens for up to one and a half years at −20 °C or −70 °C had limited influence on the ACTH levels in these specimens measured by the ARCHITECT ACTH assay. In both neat and spiked specimens at the two storage conditions, ACTH levels remained relatively stable over time with only minimal changes in ACTH levels (<11%). Storing specimens for up to four or six years did significantly reduce detectable ACTH levels in native patient plasma specimens. After four years of storage at −20 °C, ACTH levels were 74.8%, whereas after six years of storage ACTH levels were only 46.2% of the original ACTH levels measured using the Liaison immunoassay.
The authors concluded that corticotropin levels are stable in plasma when stored at −20 °C for one and a half years using the Abbott assay, but with longer storage time a significant reduction in corticotropin levels can be expected. Once specimens are stored for future corticotropin measurements, one should consider storage time, storage temperature and assay differences. The study was originally published on October 13, 2021 in the journal Clinical Chemistry and Laboratory Medicine.
Related Links:
Amsterdam University
Amsterdam University Medical Centers
Abbott Laboratories
Diasorin
Cortisol regulates ACTH release via a negative feedback loop. Measurements of plasma ACTH are crucial for differential diagnosis of endocrine disorders including Cushing’s syndrome and adrenal insufficiency but can be complicated by both preanalytical and analytical factors.
Clinical Biochemists at Amsterdam University (Amsterdam, The Netherlands) and their colleagues investigated the long-term storage stability of corticotropin in ethylenediaminetetraacetic acid containing plasma. Plasma specimens were obtained from 20 healthy American subjects that were either neat or spiked with ACTH (22–1,866 pg/ml). Plasma specimens were also obtained from Dutch patients visiting the Amsterdam University Medical Centers (UMC, Amsterdam, The Netherlands), between 2012 and 2013 for various indications.
Individual specimens were assayed on the day of processing (month 0) and five times (at 1, 3, 9, 12, and 18 months) following storage at both −20 °C and −70 °C in five replicates each. Specimens were thawed once on the laboratory countertop at room temperature, mixed by gentle inversion and centrifuged at 3,000×g for 5 minutes Afterwards they were kept at room temperature and quickly analyzed. ACTH results were generated on the ARCHITECT i2000SR automated immunoassay instrument system (Abbott Laboratories, Abbott Park, IL, USA). The team also used a chemiluminescence immunoassay (CLIA) that uses two monoclonal antibodies of which the Liaison capture antibody that is coated to magnetic particles and the detection antibody is linked to an isoluminol derivative (Diasorin, Salugia, Italy).
The team reported that storing human plasma specimens for up to one and a half years at −20 °C or −70 °C had limited influence on the ACTH levels in these specimens measured by the ARCHITECT ACTH assay. In both neat and spiked specimens at the two storage conditions, ACTH levels remained relatively stable over time with only minimal changes in ACTH levels (<11%). Storing specimens for up to four or six years did significantly reduce detectable ACTH levels in native patient plasma specimens. After four years of storage at −20 °C, ACTH levels were 74.8%, whereas after six years of storage ACTH levels were only 46.2% of the original ACTH levels measured using the Liaison immunoassay.
The authors concluded that corticotropin levels are stable in plasma when stored at −20 °C for one and a half years using the Abbott assay, but with longer storage time a significant reduction in corticotropin levels can be expected. Once specimens are stored for future corticotropin measurements, one should consider storage time, storage temperature and assay differences. The study was originally published on October 13, 2021 in the journal Clinical Chemistry and Laboratory Medicine.
Related Links:
Amsterdam University
Amsterdam University Medical Centers
Abbott Laboratories
Diasorin
Latest Clinical Chem. News
- VOCs Show Promise for Early Multi-Cancer Detection
- Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
- Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
- Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
- Simple Non-Invasive Hair-Based Test Could Speed ALS Diagnosis
- Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
- Prostate Cancer Markers Based on Chemical Make-Up of Calcifications to Speed Up Detection
- Breath Test Could Help Detect Blood Cancers
- ML-Powered Gas Sensors to Detect Pathogens and AMR at POC
- Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation
- Skin Swabs Could Detect Parkinson’s Years Before Symptoms Appear
- New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs

- New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
- Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
- Simple Urine Test Could Detect Multiple Cancers at Early Stage
- Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules
Channels
Molecular Diagnostics
view channel
New Diagnostic Method Detects Pneumonia at POC in Low-Resource Settings
Pneumonia continues to be one of the leading causes of death in low- and middle-income countries, where limited access to advanced laboratory infrastructure hampers early and accurate diagnosis.... Read more
Blood Immune Cell Analysis Detects Parkinson’s Before Symptoms Appear
Early diagnosis of Parkinson’s disease remains one of the greatest challenges in neurology. The condition, which affects nearly 12 million people globally, is typically identified only after significant... Read moreHematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read moreImmunology
view channel
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read more
Signature Genes Predict T-Cell Expansion in Cancer Immunotherapy
Modern cancer immunotherapies rely on the ability of CD8⁺ T cells to rapidly multiply within tumors, generating the immune force needed to eliminate cancer cells. However, the biological triggers behind... Read moreMicrobiology
view channel
High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
Candida bloodstream infections are a growing global health threat, causing an estimated 6 million cases and 3.8 million deaths annually. Hospitals are particularly vulnerable, as weakened patients after... Read morePathology
view channel
New Molecular Analysis Tool to Improve Disease Diagnosis
Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional... Read more
Tears Offer Noninvasive Alternative for Diagnosing Neurodegenerative Diseases
Diagnosing and monitoring eye and neurodegenerative diseases often requires invasive procedures to access ocular fluids. Ocular fluids like aqueous humor and vitreous humor contain valuable molecular information... Read moreTechnology
view channel
Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
Sorting different cell types—such as cancerous versus healthy or live versus dead cells—is a critical task in biology and medicine. However, conventional methods often require labeling, chemical exposure,... Read more
Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
Blood tests remain a cornerstone of medical diagnostics, but traditional imaging and analysis methods can be slow, costly, and reliant on dyes or contrast agents. Now, scientists have developed a real-time,... Read moreIndustry
view channel
Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
QIAGEN (Venlo, Netherlands) has entered into a definitive agreement to fully acquire Parse Biosciences (Seattle, WA, USA), a provider of scalable, instrument-free solutions for single-cell research.... Read more
Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
Puritan Medical Products (Guilford, ME, USA), the world’s most trusted manufacturer of swabs and specimen collection devices, is set to exhibit at AMP2025 in Boston, Massachusetts, from November 11–15.... Read more
Advanced Instruments Merged Under Nova Biomedical Name
Advanced Instruments (Norwood, MA, USA) and Nova Biomedical (Waltham, MA, USA) are now officially doing business under a single, unified brand. This transformation is expected to deliver greater value... Read more








